Recent advances in the management of hepatitis C virus (HCV) infection have improved the response to therapy. Predictors of a favorable response include infection with HCV genotype 2 or 3 (rather ...
Professor Harry Hausler, the CEO of TB HIV Care and a former technical advisor to the national Department of Health on TB/HIV, believes the main reason for this “massive” uptick in blood-borne ...
The hepatitis C virus (HCV) is believed to have infected approximately 170 million people worldwide (Fig. 1). Often referred to as the silent killer, patients can remain asymptomatic for decades ...